Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Therapeutics × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 6 Plasma cell 5 Breast 5 Lymphoid 4 Gastrointestinal 4 Dermatologic 4 CNS 4 Thoracic 3 Sarcoma 3 Myeloid 3 Head & Neck 3 Gynecologic 3 Tumor-Agnostic 1 Other solid neoplasm 1 Other neoplasm 1 Other 1 Genitourinary 1 Classical hematology 1

Conditions

Mucositis 1 Head and Neck Neoplasms 1

Interventions

naloxegol 6 Radiotherapy 5 Metformin 5 Exenatide 4 Surveys and Questionnaires 3 Cisplatin 3 Water 2 Vitamin D 2 Sugars 2 Radiation 2 Methods 2 Injections 2 Dexamethasone 2 Calcium Dobesilate 2 Anastrozole 2 prucalopride 1 peppermint oil 1 penclomedine 1 pegfilgrastim 1 oxycodone-acetaminophen 1 methylnaltrexone 1 linaclotide 1 licogliflozin 1 kang-lai-te 1 isatuximab 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 dapagliflozin 1 cyclohexaneacetic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04046250 2023-08-25

TK112690

Tosk, Inc.

Phase 2 Completed

22 enrolled 10 charts

Head & NeckOther

Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡